Quick Dispatch:
Your glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology ships.
Need Help?
Questions about glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and prostate cancer Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents | Discover Oncology in your area.
Attenuation of prostate cancer cell proliferation by overexpression of
21.98
GLP-1 Agonists May One Day Treat Prostate Cancer
24.25
GLP-1 drugs linked to major slowdown in cancer spread, new study finds
20.25
GLP-1 agents linked to lower cancer risk among adults with obesity
27.67
The Novel Dual GIP and GLP‐1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism - Zhang - 2025 - Advanced Science
23.08
Liraglutide Shows Anticancer Effects in Breast Prostate Cancer | Bassem Refaat posted on the topic
25.48
GLP1 receptor agonism alters growth and therapeutic response in prostate cancer
26.90
